News Search Results
Aug 27, 2025, 15:28 ET The Galien Foundation Announces 2025 Prix Galien USA Nominees for "Best Digital Health Solution," "Best Medical Technology," "Incubators, Accelerators and Equity," and "Best Startup"
Shenzhen ReeToo Biotechnology Co., Ltd.
More news about: The Galien Foundation
Aug 27, 2025, 15:17 ET CAGE Bio Announces Collaboration to Advance First-in-Class Treatments for Cutaneous Graft versus Host Disease
value of CAGE Bio's ionic liquid technology for developing critical therapies for patients." About CAGE Bio Inc. CAGE Bio Inc. is a biotechnology company dedicated to developing innovative therapies for immune-mediated diseases using its proprietary ionic liquid technology platform. The company's
More news about: CAGE Bio Inc.
Aug 27, 2025, 12:45 ET Northwest Biotherapeutics Announces Agreement to Acquire Advent BioServices Ltd.
Aug. 27, 2025 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced that it has entered into an agreement to acquire Advent
More news about: Northwest Biotherapeutics, Inc.
Aug 27, 2025, 12:39 ET Northwest Biotherapeutics Announces Agreement to Acquire Advent BioServices Ltd.
Aug. 27, 2025 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced that it has entered into an agreement to acquire Advent
More news about: Northwest Biotherapeutics, Inc.
Aug 27, 2025, 10:43 ET 晶泰控股發佈 2025 年上半年業績報告
備突破性治療潛力的 PRMT5 抑制劑 PE-0260，目前，智擎生技已完成IND申報，並已經啟動了臨床試驗。我們與孵化公司希格生科合作的全球首款瀰漫性胃癌靶向藥物，獲得「醫藥界的諾貝爾獎」蓋倫獎（Prix Galien Awards) 最佳生物技術產品獎（Best Biotechnology Product）提名，我們獲提名的管線是本次唯一來自亞洲的管線，也是該獎項50多年來 第四次 提名中國公司。得益於前期訂單的高質量交付，抗體業務在 2025 年上半年實現收入的大幅增長, 達到 2024 年全年收入的近二倍。 抗體業務已與多家國際知名藥企開展深度合作，業務角色也由服務提供商逐步升級為平台型的聯合開發者，顯著提升了單一客戶的生命週期價值。晶泰AI賦能孵化企業萊芒生物，兩條管線取得重要進展。（1）其代謝增強型CD19
More news about: 晶泰科技
Aug 27, 2025, 10:40 ET Harbour BioMed Reports 2025 Interim Results
In February 2025, Harbour BioMed entered into a strategic collaboration with Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, to accelerate the discovery of novel therapeutic antibodies by combining complementary strengths in antibody discovery
More news about: Harbour BioMed
Aug 27, 2025, 10:23 ET XtalPi Holdings Announces 2025 Interim Results
co-developed with incubated company Signet Therapeutics, was nominated for the prestigious Prix Galien Award for Best Biotechnology Product, often hailed as the "Nobel Prize of the pharmaceutical industry". This was the only Asian pipeline nominated this year and only the fourth
More news about: XtalPi Inc.
Aug 27, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain Officers - UNCY
[Click here for information about joining the class action] Unicycive is a clinical-stage biotechnology company that identifies, develops, and commercializes therapies to address unmet medical needs in the U.S. The Company is developing, among other
More news about: Pomerantz LLP
Aug 27, 2025, 09:00 ET BioMarin to Participate in Upcoming Investor Conferences
available through the Company's website for a limited time following the conference. About BioMarinBioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The San
More news about: BioMarin Pharmaceutical Inc.
Aug 27, 2025, 09:00 ET Evommune Initiates Phase 2b Trial of its Oral MRGPRX2 Antagonist, EVO756, in Adults with Moderate to Severe Atopic Dermatitis
Calif., Aug. 27, 2025 /PRNewswire/ -- Evommune, Inc., a clinical stage biotechnology company discovering and developing innovative therapies that target key drivers of chronic inflammatory diseases, today announced the enrollment
More news about: Evommune, Inc
Aug 27, 2025, 09:00 ET Portfolia Launches Women's Health Fund IV, Building on its 46-Company Women's Health Portfolio
Fund IV's debut investment is in Gameto, a clinical-stage biotechnology company reprogramming female cells to transform fertility and hormonal care. Portfolia's investment is part of Gameto's recently announced
More news about: Portfolia
Aug 27, 2025, 08:30 ET Analytical Platform for Rapid, Reliable mRNA Modality Analytics, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Aug 27, 2025, 08:30 ET Hot Melt Extrusion: Accelerating Drug Development for Poorly Soluble APIs, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Aug 27, 2025, 08:30 ET Scalable VHH and Peptide Secretion Platform Using C. glutamicum, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Aug 27, 2025, 08:30 ET Advancing the Next Parkinson's Disease Breakthrough: Keys to Successful Clinical Trials, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Aug 27, 2025, 08:30 ET Applying a Holistic Digital Endpoint Strategy in the Development of Congestive Heart Failure Treatments, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Aug 27, 2025, 08:00 ET Actinogen trial using intended commercial Xanamem tablet formulation confirms target exposures in fed and fasted states
Limited About Actinogen Medical Actinogen Medical (ACW) is an ASX-listed, biotechnology company in the late clinical stages of development for Xanamem® (emestedastat), its novel oral therapy for Alzheimer's disease and depression. The
More news about: Actinogen Medical Limited
Aug 27, 2025, 07:00 ET Leal Therapeutics Announces $30 Million Series A to Progress First-In-Class Neuro-Metabolic Therapies for Neurodegenerative and Neuropsychiatric Disorders with High-Unmet Need
Mass., Aug. 27, 2025 /PRNewswire/ -- Leal Therapeutics, Inc., a biotechnology company developing novel therapeutics for patients with disorders of the central nervous system (CNS), today announced a $30
More news about: Leal Therapeutics
Aug 27, 2025, 07:00 ET Adcendo ApS to Participate in Upcoming September Investor Conferences
2025Location: Boston, MAAbout Adcendo Adcendo is a clinical-stage biotechnology company headquartered in Copenhagen, Denmark, with operations in Boston, Massachusetts.
More news about: Adcendo
Aug 27, 2025, 07:00 ET Adcendo ApS to Participate in Upcoming September Investor Conferences
2025Location: Boston, MAAbout Adcendo Adcendo is a clinical-stage biotechnology company headquartered in Copenhagen, Denmark, with operations in Boston, Massachusetts.
More news about: Adcendo
Aug 27, 2025, 06:45 ET Lilly's Verzenio® (abemaciclib) increases overall survival in HR+, HER2-, high-risk early breast cancer with two years of therapy
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Aug 27, 2025, 06:30 ET Shineco (NASDAQ: SISI) & BICC: From "Tech On-Chain" to "Global Redeemability"--RWA Ecosystem Takes Off for Long-Term Growth
the ecosystem and will continue to update on project progress." About BICC Pte Ltd Founded in 2024, BICC is an innovative biotechnology holding company that unites a world-class team of scientists and medical experts specializing in stem cell treatments and artificial intelligence.
More news about: Shineco,Inc.
Aug 27, 2025, 06:30 ET Global CAR-T Cell Therapy Market to Hit $217.6Bn by 2035 at 39.75% CAGR | Vantage Market Research
Research is a trusted partner to Fortune 500 companies and leading biopharma firms, delivering actionable market intelligence across healthcare, biotechnology, and advanced cell therapies. Our globally recognized insights empower stakeholders to make informed decisions and capitalize on emerging opportunities.
More news about: Vantage Market Research
Aug 27, 2025, 06:08 ET Innovent Announces 2025 Interim Results and Business Updates
from Innovent's innovative drugsInnovent has been graded 'AAA' rating in MSCI ESG rankings, positioning us at the forefront of the biotechnology industryWe have supported over 200,000 patients through our dedicated patient assistance programs, with drug donations totaling RMB
More news about: Innovent Biologics
Aug 27, 2025, 03:09 ET BPC Instruments reports results for H1 and Q2 2025
awarded one of Sweden's leading environmental prizes for its innovative work in renewable energy and environmental biotechnology. On 4 June, BPC received a 0.7 MSEK from KU Leuven, Belgium's highest-ranked university and one of the oldest
More news about: BPC Instruments AB